Merck to Buy Australian Firm to Boost Immunotherapy Pipeline – Zacks.com
Zacks.comMerck to Buy Australian Firm to Boost Immunotherapy PipelineZacks.comMerck & Co., Inc. (MRK – Free Report) has proposed to buy Viralytics Limited, an Australian pharmaceutical company that develops oncolytic immunotherapies for a range of … Continue reading
